恆指跌幅擴至580點失守26,200 重磅股及創科挫逾2%-4% 兩大藥股逆升逾1%
美股本周走勢有如過山車,昨晚三大指數收市再度急吐3.1%-3.6%,歐洲及美國新冠肺炎疫情迅速擴散,首現死亡病例加州進入緊急狀態,投資者憂慮疫情進一步惡化衝擊經濟,貼債息走低的銀行股、工業科技及非藍籌郵輪等旅遊相關股首當其衝全面急挫,拖累道指跌幅曾瀉1,147或4.2%失守二萬六關,蒸發前晚呈報復性勁彈4.5%大部分升幅,收挫3.6%。美股期貨全面續跌逾1%,道指期貨報25,792,續挫268點。亞太區股市無一倖免,尤其是澳股、韓股及日經依次急吐2.1%-3.2%,受累圓匯升破106創半年高的後者失守20,700,創半年低。港股也蒸發昨天急彈545點所有升幅,恆指今天低開370點或1.4%,跌幅擴至580點或2.1%,報26,187,成交額491億元。藍籌股除石藥(01093.HK)及中生製藥(01177.HK)逆市續升1.1%-1.8%分別報18.92元及12.56元外,無一倖免,跌幅普遍逾1%-2%;舜宇(02382.HK)、申洲(02313.HK)、內房潤地(01109.HK)/碧桂園(02007.HK)、九倉置業(01997.HK)、濠賭股銀娛(00027.HK)/金沙(01928.HK)、中信股份(00267.HK)及創科(00669.HK)更吐3%-4.5%,後者最傷報64.4元,股價一舉失守50天、20天及10天線。重磅股騰訊(00700.HK)、匯控(00005.HK)、建行(0939.HK)及三大保險股也吐2%-2.7%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.